JTA NEWS
21 September 2014 - 26 Elul 5774 - כ"ו אלול ה' אלפים תשע"ד
JTA NEWS :
Business
EL AL appoints David Maimon as CEO E-mail

El Al Israel Airlines Ltd recently announced that its board of directors has appointed David Maimon as CEO to succeed Brigadier General (Res) Elyezer Shkedy who is ending his term of office after 4 years.

Amikam Cohen, EL AL Chairman of the Board of Directors, congratulated the CEOelect and wished him success. Cohen and the airline’s Board of Directors thanked Elyezer Shkedy for his 4 years of working to advance EL AL and noted that Shkedy’s special personality, leadership skills and contribution to EL AL merit special esteem.

During the past 9 years Maimon has served in various positions at EL AL. In his last position he was EL AL Vice President Commercial and Aviation Ties and led the company’s commercial and marketing policy. Prior to this position he was EL AL’s Vice President of Sales and Vice President of Services.

Please login or register to see the full article
 
Singapore Airshow 2014 E-mail

Just as one important defence exhibition concludes in India, one of the most important air shows in the world is held in the same month in Singapore. The Singapore Airshow 2014 took place from 11-16 February at the Changi Exhibition Centre.

Israeli Defense Minister Moshe Ya’alon participated in the opening ceremony of the International Air Show where Israeli Aerospace Industries presented a number of new military aircraft on the cutting edge of defense technology. “From the technology displayed here at the booths of the Defense Ministry, I can say that Israel is a superpower,” Ya’alon stated during the ceremony. “The fact that Israel is represented here in this way, in a place so far from home, shows me that Israel is a superpower in this respect, at least.”

“Israel is a reluctant superpower because it seems that threats and danger provide a better incentive to develop new military innovations in a wide variety of fields,” he continued. “We face the threats of a changing Middle East, and despite being smaller [than our neighbors] in every way, our ability to respond is based mainly on or minds and hearts, on our knowledge and spirit. This knowledge, this spirit drives the soldiers who fight, [and] drive the navy and the air force.”

“Not any less important are our engineers, scientists and technicians in various industries, who actualize our military capabilities for our soldiers,” he added.

“The world is undergoing quite a few changes that directly affect the defense ministry, not to mention economic and social changes,” Ya’alon noted. “Our relatively stable security situation rests largely on our ability to respond to our more intimidating ordeals, and the partnership between those at the front and those on the laboratory bench, between the designer and the commander [. . .] is the guarantee to our security.

Please login or register to see the full article
 
Excellence in Business with Japan Award Ceremony E-mail

A traditional ceremony event arranged every year by the Israel-Japan Chamber of Commerce in Tokyo was recently held. Over 150 Israeli business executives packed the auditorium in January for the Excellence in Business with Japan 2013 Award Ceremony.

The winners are leading Israeli companies by trading volume with Japan. This year, for the first time, the event also marked companies with innovation in business with Japan.
Keynote speaker at the event was Israel’s Minister of Agriculture, Yair Shamir, who also gave a review of his visit to Japan a few months previously.

Dr. Roni Bornstein, chairman of the Israel-Japan Chamber of Commerce, said that the map of Israeli exports to Japan is undergoing a refreshing change. Alongside the export of industrial products, hightech and medical equipment, the Japan-Israel Chamber of Commerce identified two new trends. The first one is new mergers and acquisitions. Israeli companies acquiring Japanese companies which employ thousands of Japanese workers. Such is the case with Teva its Japanese presence includes manufacturing and packaging sites, employing thousands of workers – all Japanese. Comverse, another 2013 winner, also employs about 120 employees in their Tokyo and Osaka offices.

The second trend is the successful penetration of Israeli companies to the Japanese consumer market with new Israeli consumer products. The Japanese consumer market is the second largest in the world after the US. As such, it is a fantastic opportunity for Israeli companies. “Israeli companies were extremely successful in this difficult market, introduced the “blue and white” branding and exposed Japanese consumers to products with a tag of Israeli identity.” In his remarks Mr. Bornstein was referring mainly to products ‘Made In Israel’ and available in Japan by four new Award Winners of 2013. This included Body Care products from Sabon, Chocolates from Max Brenner, and the award winning machine from SodaStream.

Another Award winner this year was Yaskawa Europe Technology, which is the investment arm of Japan-based robotics expert Yaskawa Electric Corporation, that invested in Israeli start-up Argo Medical Technologies, makers of the ReWalk exoskeleton walking suit for spinal injury victims.

Please login or register to see the full article
 
Pluristem Therapeutics and CHA Bio segment strategic partnership E-mail

Israeli based Pluristem Therapeutics Inc, a developer of placenta-based cell therapies and South Korean company CHA Bio&Diostech, a leading biopharmaceutical company, have entered into investment agreements to which Pluristem has issued to CHA shares to a value of US$$10.4 million. The shares are subject to a lock up period of one year.

The announced agreement with CHA encompasses the use of Pluristem’s PLX-PAD cells in the treatment of two subsets of peripheral artery disease in South Korea.

Zami Aberman, Pluristem’s Chairman and CEO stated, “We are excited to finalize and move forward with this strategic agreement with CHA Bio. We believe that initiating clinical trials with CHA Bio for indications in the area of peripheral vascular disease opens significant opportunities for Pluristem in South Korea’s dynamic regenerative medicine industry. We also look forward to potentially expanding the use of our PLX cells for other indications with our partner, CHA Bio.”

The first clinical study to be performed as part of the agreement will be a Phase II trial in IC which will run in parallel to the Phase II trial being conducted in the US, Germany and Israel. This study was approved in November 2013 by South Korea’s Ministry of Food and Drug Safety.

Please login or register to see the full article
 
Israel Aerospace Industries opens Singapore R&D cyber centre E-mail

Israel Aerospace Industries Ltd. (IAI) and the Singapore government on 13 February 2014 unveiled the company’s Cyber Early Warning R&D Center in Singapore.

The centre will employ Singaporean research scientists, computer analysts, and engineers to develop innovative cyber early warning technologies.

The centre is modeled on IAI’s cyber-accessibility centre in Israel, with the goal of tackling complex cyber problems. It will develop prototypes for cyber early warning solutions, mature prototypes into fullyfledged customer-grade solutions, and market the solutions in Singapore and other countries.

It will closely cooperate with IAI to ensure that its R&D roadmap coincides with the company’s development roadmap, strategy and longterm goals. Initial research will focus on critical and emerging areas, including, but not limited to active defense capabilities to identify cyber attackers in real time, cyber geo-location resolution to identify the physical location of cyber attackers, and advanced anomaly detection capabilities to identify deviations from routine behavior.

“We are excited and honored to have the support of the Singapore Economic Development Board for the establishment of our cyber early warning R&D center in Singapore,” said IAI CEO Joseph Weiss.

Please login or register to see the full article
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Jewish Times Asia is published by Jewish Times Asia Ltd. © Copyright 2014.
Material in the newspaper or on this site may not be used or reproduced in any form or in any way without permission from the editor.
While every effort has been made to ensure the content is true and accurate, the publisher is not responsible for any errors or omissions in the printed text.